Peter R. Manninen

Synthesis and Antibacterial Activity of U-100592 and U-100766, Two Oxazolidinone Antibacterial Agents for the Potential Treatment of Multidrug-Resistant Gram-Positive Bacterial Infections

Steven J. Brickner, Douglas K. Hutchinson, Michael R. Barbachyn et al. · Journal of Medicinal Chemistry · 1996 · 570 citations

Antibacterial Activity, Antimicrobial Chemotherapy, Drug Resistance +16

Discovery of 6-(4-{[5-Cyclopropyl-3-(2,6-dichlorophenyl)isoxazol-4-yl]methoxy}piperidin-1-yl)-1-methyl-1<i>H</i>-indole-3-carboxylic Acid: A Novel FXR Agonist for the Treatment of Dyslipidemia

Michaël Génin, Ana B. Bueno, Javier Agejas Francisco et al. · Journal of Medicinal Chemistry · 2015 · 57 citations · Full text

Pharmaceutical Science, Selective Fxr Agonist, Farnesoid X Receptor +18

Synthesis and antibacterial activity of [6,5,5] and [6,6,5] tricyclic fused oxazolidinones

D. M. GLEAVE, Steven J. Brickner, Peter R. Manninen et al. · Bioorganic & Medicinal Chemistry Letters · 1998 · 35 citations

Medicinal Chemistry, Bioorganic Chemistry, Heterocyclic +7

Discovery and characterization of [(cyclopentyl)ethyl]benzoic acid inhibitors of microsomal prostaglandin E synthase-1

Katherine M. Partridge, Stephen Antonysamy, Shobha Bhattachar et al. · Bioorganic & Medicinal Chemistry Letters · 2016 · 27 citations · Full text

Medicinal Chemistry, Chemoprevention Strategy, Biochemistry +8

Characterization of 3,3-dimethyl substituted N-aryl piperidines as potent microsomal prostaglandin E synthase-1 inhibitors

Steven L. Kuklish, Stephen Antonysamy, Shobha Bhattachar et al. · Bioorganic & Medicinal Chemistry Letters · 2016 · 26 citations · Full text

Medicinal Chemistry, Pharmaceutical Science, Biochemistry +8